Phase I Study of Prolonged Infusion Bryostatin-1 in Patients

Cancer Biology and Therapy - United States
doi 10.4161/cbt.1.4.17
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Phase I Study of 21 Days Continuous Infusion With Vindesine

British Journal of Cancer
Cancer ResearchOncology
1989English

Phase I–II Trial of Prolonged Gemcitabine Infusion Plus Paclitaxel as a Biweekly Schedule for Advanced Breast Cancer Patients Pretreated With Anthracyclines

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2010English

Efficiency and Safety of Prolonged Levosimendan Infusion in Patients With Acute Heart Failure

Cardiology Research and Practice
Cardiovascular MedicineCardiology
2011English

Phase I Study of Nivolumab, an Anti-Pd-1 Antibody, in Patients With Malignant Solid Tumors

Investigational New Drugs
OncologyPharmacology
2016English

Anti-Pd-1 Monoclonal Antibody MEDI0680 in a Phase I Study of Patients With Advanced Solid Malignancies

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

A Phase I Study of Indoximod in Patients With Advanced Malignancies

Oncotarget
Oncology
2016English

Towards the Asymmetric Synthesis of Bryostatin 1

Pure and Applied Chemistry
ChemistryChemical Engineering
1996English

Phase I Study of Temozolomide in Paediatric Patients With Advanced Cancer

British Journal of Cancer
Cancer ResearchOncology
1998English

Phase I Clinical Trial of Hepatic Arterial Infusion of Paclitaxel in Patients With Advanced Cancer and Dominant Liver Involvement

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy